Torrent Pharmaceuticals Ltd.

is a mid-cap pharma company with strong presence in cardiac, respiratory, and gastrointestinal therapeutic areas. The company has a robust pipeline of generic launches and APIs supporting consistent revenue growth. Torrent's focus on emerging markets and API manufacturing provide diversified revenue sources. Challenges include US price pressures, regulatory scrutiny at manufacturing sites, and integration of recent acquisitions.